Brett Schulman

CEO Brett Schulman sells 33,174 shares of CAVA at $89.43; retains 798,669 shares post-sale with stock at $88.05.

Brett Schulman, CEO and President, sold 33,174 shares (33.2K shares) on 2026-06-15 at $89.43, reducing his holdings by 4.0% from 831,843 to 798,669 shares. The sale occurred near the stock's 52-week high of $98.79 (within 10.9%), shortly after a 30-day gain of 10.2%. At CAVA specifically, Schulman's prior four sales generated mixed timing outcomes: two sales in June 2025 showed positive 30-day returns (+16.9%, +18.7%) but were poorly timed at the 90-day mark (+42.8%, -16.4%, -15.1%), while a January 2025 sale was both poorly timed on 30-day (+4.0%) and well-timed at 90-day (-1.0%, -32.9%). The cross-ticker track record shows 16 prior sells with a 62.50% well-timed rate and a -1.4% average 30-day return, but this current sale lacks the sell-timing context that would clarify near-term directional signal. The stock's current price of $88.05 sits below the $89.43 transaction price, and with a 166.13 P/E and 22.4% revenue growth, valuation context for the sale remains ambiguous absent forward guidance or market-specific commentary.

CAVA CEO Brett Schulman sold 21,650 shares at $67.41 on 2026-01-21; stock now -53.6% from 52-week high of $142.90

Brett Schulman, CAVA's CEO and President, sold 21,650 shares for $1,459,426.50, reducing holdings from 829.0K to 807.3K shares (-2.6%). The transaction occurred at $67.41 per share; the stock has since fallen to $66.32, now trading 53.6% below its 52-week high of $142.90. Schulman's prior trades at CAVA show 4 of 4 have been well-timed at the 90-day mark, including his two most recent January 2025 sales which saw 90-day declines of -32.5% and -32.9%. However, his cross-ticker sell history (15 prior sales, 66.67% well-timed rate at 90 days, avg 90d return -13.9%) provides less decisive evidence of systematic market timing than his CAVA-specific pattern. The company trades at a 56.20 P/E multiple despite robust 32.2% annual revenue growth, which may explain the valuation compression from $142.90 to the current price.

CEO Schulman buys 150 CAVA shares at $48.98; stock down -67.7% from 52-wk high, down -23.0% in 30 days

Schulman, as CEO and President, purchased 150 shares at $48.98 on 2025-11-12, establishing his first stake at this company. The purchase occurs amid significant recent price deterioration: CAVA is trading down -67.7% from its 52-week high of $150.88 and down -23.0% over the past 30 days. Historically, Schulman's prior 5 trades at CAVA were all sells, with a 100% well-timed rate at the 90-day mark (negative 90-day returns in all cases). His cross-ticker track record shows 15 prior sells with a 66.67% well-timed rate over 90 days. The shift from repeated selling to a buy merits observation given the stock's severe drawdown, though the small 150-share position ($7.3K) limits visibility into any larger strategic shift.

CEO Brett Schulman sold 31,856 CAVA shares for $2,394,154.16 on 2025-06-16 at $75.16 avg; stock now -17.3% in 30 days

Schulman sold 2 separate tranches totaling 31,856 shares (31.9K shares) for $2,394,154.16 at a blended average price of $75.16, reducing holdings by 3.9%. The stock has since fallen 17.3% over the past 30 days and 12.1% over 90 days, trading 50.7% below its 52-week high of $150.88. His prior five sales at CAVA exhibited a 100% well-timed rate at the 90-day mark, with negative returns following each sale. This transaction follows the same pattern: a CEO sale executed during a period of significant stock depreciation, consistent with his historical execution timing at this ticker. The current P/E of 60.53 and annual revenue growth of 32.2% represent the fundamental context at the time of sale.

CAVA CEO Brett Schulman sold 20,564 shares for $2,450,732.86 on 2025-01-21 at $119.18 blended average.

CEO Brett Schulman executed 2 separate sales totaling 20,564 shares for $2,450,732.86 on 2025-01-21, reducing his holding from 796,933 shares to 776,369 shares (a 2.6% reduction). The sales occurred at a blended average price of $119.18, while the current price stands at $124.01—placing the transaction 4.7% below current levels. Schulman's cross-ticker track record shows an average 90-day return of +20.1% after his 11 prior sells across all tickers, with a well-timed rate of 0.00%, indicating his prior sales have typically been followed by stock appreciation rather than declines. At CAVA specifically, his 5 prior trades show mixed near-term outcomes: the most recent measurable sale on 2024-12-05 posted a 30-day return of -23.3%, though longer-term patterns at this ticker remain incomplete. CAVA's fundamentals present an extreme valuation picture with a P/E of 563.68 and annual revenue growth of +29.2%, which may provide context for insider decision-making even as the stock remains -17.8% from its 52-week high of $150.88.

CEO Brett Schulman sells 14,214 shares in 2 transactions for $1,633,683.18 (blended avg $114.93); retains 796,933 shares.

Brett Schulman, CEO and President, executed 2 separate sales totaling 14,214 shares for $1,633,683.18 on 2025-01-02 at an average price of $114.93 per share, reducing his holdings by 1.8% to 796,933 shares. The stock currently trades at $118.88, 21.2% below its 52-week high of $150.88 and down 21.2% over the past 30 days. Schulman's prior CAVA trades, all recent sales on 2024-12-05, have declined 23.3% in the 30 days following those transactions, though his broader cross-ticker track record shows sells that averaged a positive 90-day return of 20.1%, indicating this insider's historical timing has been weak on downside protection. With CAVA's P/E of 540.36 and 29.2% annual revenue growth, the stock remains highly valued relative to near-term earnings.

CAVA CEO Schulman sold 327,000 shares for $49.1M on 2024-12-05; stock down 12.1% from 52-week high since

Brett Schulman, CEO and President, executed 4 separate sales totaling 327,000 shares for $49,069,620.00 at $150.06 on 2024-12-05, reducing his holdings by 28.7% from 1.14M to 811.1K shares. The current price of $132.57 sits 12.1% below the 52-week high of $150.88, meaning the stock has declined since the transaction executed near peak levels. His prior trades at CAVA show a timing pattern where 0 of 5 prior sells captured downside effectively—four of those five sells were followed by positive 90-day returns ranging from +14.1% to +39.2%, indicating prior sales occurred before subsequent rallies. The company shows strong fundamentals with 29.2% annual revenue growth, though the P/E of 602.59 reflects an extremely high valuation multiple typical of unprofitable or near-profitless growth companies.

CAVA CEO Schulman sells 201,504 shares for $25.3M at $125.53 avg, retains 716,090 shares post-sale

Brett Schulman, CAVA's CEO and President, executed 4 separate sales on 2024-08-26 totaling 201,504 shares for $25,294,557.20 at a blended average price of $125.53, reducing his holdings from 917,594 shares to 716,090 shares (a -22.0% reduction). The sales occurred near the company's 52-week high of $125.80, with the stock currently trading at $118.44 (-5.8% from that peak). Schulman's cross-ticker track record shows 1 prior sell with an average 30-day return of -6.5%; at CAVA specifically, his prior sell on 2024-06-14 also yielded a -6.5% 30-day return. The timing context is important: the company is growing revenue at +29.2% annually, yet carries an unusually elevated P/E ratio of 538.36, reflecting investor expectations that may leave limited margin for disappointment. The sale size—22% of pre-transaction holdings—represents a material reduction in CEO stake at a moment when valuation multiples are extreme relative to earnings power.

CEO Schulman sold 66.4K CAVA shares at $90.11 for $6.0M; stock now at 52-week high of $95.39.

CEO and President Brett Schulman sold 66,414 shares at $90.11 on 2024-06-14, reducing his holdings from 970,508 to 904,094 shares. The sale occurred when CAVA was trading modestly below its current price of $95.39, which marks the 52-week high. The company has demonstrated strong fundamental momentum with annual revenue growth of +29.2%, and the stock has appreciated +23.4% over the prior 30 days and +39.6% over 90 days. While the sale represents a 6.8% reduction in CEO holdings, the transaction occurred during a period of significant stock appreciation and near peak valuation levels, warranting investor attention to executive positioning relative to recent price momentum.